In silico Analysis of Small Molecules With Possible SARS-CoV-2 RNA-Dependent RNA Polymerase Inhibiting Properties and Their Therapeutic Potential
Overview
Since an effective and reliable antiviral drug against COVID-19 (caused by the SARS-CoV-2 virus) has not been developed, research on novel therapeutic targets is crucial. The RdRp protein of SARS-CoV-2 was the perfect target because this protein is exclusive only to viruses while also being an extremely under-researched protein. An in silico project was optimal for examining the RdRp of SARS-CoV-2 as a therapeutic target. A library of synthetically-available small-molecule compounds was prepared, and virtual screening on the active site of SARS-CoV-2 RdRp using structure-based docking was performed. Several compounds proved to be bonded to the binding site of the RdRp with a uniquely low binding affinity. These compounds were further tested in vitro to determine the IC50 through enzyme assays. The binding of the small molecules onto the RdRp was also confirmed with binding assays. Ultimately, several molecules were found to clearly inhibit RNA production efficiently in the RdRp. Furthermore, of the compounds screened, several compounds belonged to a uniquely prevalent structural cluster, with a central amide linker connecting piperidine and indazole ring systems, which could possibly represent a novel class of COVID-19 inhibitors. With these data, future studies could conduct in vitro experiments to confirm this possible drug design, and lead to novel drugs to fight the COVID-19 global pandemic. Furthermore, these compounds could also apply to any virus that is structurally similar to SARS-CoV-2. The discovery of these novel COVID-19 inhibitors based on the RdRp of SARS-CoV-2 in silico and in vitro could also possess applications against novel diseases, therefore preventing the onslaught of another COVID-19-like pandemic.
Competition history
- ISEF 2022
Resources
Related projects
ISEF · 2021
Molecular Docking Analysis of Novel SARS-CoV-2 Inhibitors Based on Structural Homology
ISEF · 2021
Analyzing the Efficacies of Potential Inhibitors of Drug Targets Human Receptor ACE2 and Viral Replication Enzyme RdRp Against SARS-CoV-2
ISEF · 2021
Evaluating the Efficacy of Repurposed and Modified Traditional Eastern Medicinal Compounds on Coronavirus Family Specific Target Structures
JSHS · 2022
Identifying Promising Antiviral Drug Candidates Against SARS-CoV-2 Using Computational Drug Repurposing Methodology
ISEF · 2021
Potential Treatment Targets for Covid-19: A Virtual Screening
ISEF · 2021
In-silico Prediction of Desoxyhavannahine as a Potential Novel Inhibitor of SARS-COV-2 with Minimal Side Effects
ISEF · 2022
Identification of Potential Inhibitors of Severe Acute Respiratory Syndrome Coronavirus 2 Envelope Protein Ion Channel Activity Using Machine Learning Techniques
ISEF · 2023
A Study of the Complex of Human Protein IRF3 and Viral Protein (SARS-CoV-2) ORF7a
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair